Cite this article

NIDA. (2007, November 27). NIDA Announces New Avant-Garde Award for Innovative AIDS Research. Retrieved from

press ctrl+c to copy

Award intended to stimulate scientists of exceptional creativity to study concepts and approaches in the forefront of drug abuse and HIV/AIDS research

November 27, 2007

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), announced today it is looking for scientists of exceptional creativity to apply for its new NIDA Avant-Garde Award for HIV/AIDS research. In a move to stimulate high-impact research into the link between drug abuse prevention and treatment and HIV/AIDS, NIDA will provide up to $500,000 per year for five years to two or three scientists of exceptional creativity who propose cutting edge - and possibly transformative - approaches to major challenges in biomedical and behavioral research on drug abuse and HIV/AIDS.

"Like the NIH Director's Pioneer Awards that have already brought many new ideas to the broad field of biomedical research, NIDA's Avant-Garde award promises to stimulate research in the intersection of drug abuse and HIV/AIDS," said Dr. Elias A. Zerhouni, NIH director. "This award provides investigators with the resources and flexibility needed to pursue potentially groundbreaking discoveries."

"We are looking for innovative thinkers who are willing to explore ideas that might be considered risky at their inception," added Dr. Nora. D. Volkow, NIDA director. "Applicants will have the intellectual and scientific freedom to pursue their ideas and follow them in expected or even unexpected directions."

Applicants will undergo a rigorous selection process to establish each proposal's potential for high-impact contributions to drug abuse research on HIV/AIDS research. Applications for the 2008 Avant-Garde Award will be accepted until March 26, 2008. For further information or to submit a nomination, visit the NIDA director's Avant-Garde Award Web site at